335 related articles for article (PubMed ID: 17636664)
1. WITHDRAWN: Gonadotrophin-releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
Daya S
Cochrane Database Syst Rev; 2007 Jul; (1):CD001299. PubMed ID: 17636664
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
Daya S
Cochrane Database Syst Rev; 2000; 2000(2):CD001299. PubMed ID: 10796763
[TBL] [Abstract][Full Text] [Related]
3. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
[TBL] [Abstract][Full Text] [Related]
4. Gonadotrophin-releasing hormone antagonists for assisted conception.
Al-Inany H; Aboulghar M
Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
[TBL] [Abstract][Full Text] [Related]
5. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Siristatidis CS; Gibreel A; Basios G; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD006919. PubMed ID: 26558801
[TBL] [Abstract][Full Text] [Related]
6. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
[TBL] [Abstract][Full Text] [Related]
7. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
[TBL] [Abstract][Full Text] [Related]
8. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.
Albuquerque LE; Tso LO; Saconato H; Albuquerque MC; Macedo CR
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD002808. PubMed ID: 23440788
[TBL] [Abstract][Full Text] [Related]
9. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
Van Wely M; Westergaard LG; Bossuyt PM; Van der Veen F
Cochrane Database Syst Rev; 2003; (1):CD003973. PubMed ID: 12535497
[TBL] [Abstract][Full Text] [Related]
10. Luteal phase support for assisted reproduction cycles.
van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
[TBL] [Abstract][Full Text] [Related]
11. WITHDRAWN: Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
Westergaard LW; Bossuyt PM; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD003973. PubMed ID: 21328264
[TBL] [Abstract][Full Text] [Related]
12. In vitro fertilisation and gamete intrafallopian transfer: an integrative analysis of research, 1987-1992.
Kenny DT
Br J Obstet Gynaecol; 1995 Apr; 102(4):317-25. PubMed ID: 7612516
[TBL] [Abstract][Full Text] [Related]
13. WITHDRAWN: Luteal phase support in assisted reproduction cycles.
Daya S; Gunby JL
Cochrane Database Syst Rev; 2008 Jul; (3):CD004830. PubMed ID: 18646113
[TBL] [Abstract][Full Text] [Related]
14. Luteal phase support in assisted reproduction cycles.
Daya S; Gunby J
Cochrane Database Syst Rev; 2004; (3):CD004830. PubMed ID: 15266541
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
Daya S; Gunby J
Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
[TBL] [Abstract][Full Text] [Related]
16. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
17. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
Daya S; Gunby J
Cochrane Database Syst Rev; 2000; (4):CD002810. PubMed ID: 11034767
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
[TBL] [Abstract][Full Text] [Related]
19. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
Al-Inany HG; Youssef MA; Aboulghar M; Broekmans F; Sterrenburg M; Smit J; Abou-Setta AM
Cochrane Database Syst Rev; 2011 May; (5):CD001750. PubMed ID: 21563131
[TBL] [Abstract][Full Text] [Related]
20. Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?
Craft I; Gorgy A; Hill J; Menon D; Podsiadly B
Hum Reprod; 1999 Dec; 14(12):2959-62. PubMed ID: 10601078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
